SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-154314
Filing Date
2021-12-29
Accepted
2021-12-29 17:00:31
Documents
14
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2136474d2_10ka.htm   iXBRL 10-K/A 180906
2 EXHIBIT 31.1 tm2136474d2_ex31-1.htm EX-31.1 3438
3 EXHIBIT 31.2 tm2136474d2_ex31-2.htm EX-31.2 3501
  Complete submission text file 0001104659-21-154314.txt   392002

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arth-20210930.xsd EX-101.SCH 3043
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arth-20210930_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arth-20210930_pre.xml EX-101.PRE 22371
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2136474d2_10ka_htm.xml XML 5033
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

IRS No.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K/A | Act: 34 | File No.: 000-54986 | Film No.: 211529582
SIC: 3841 Surgical & Medical Instruments & Apparatus